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Tissue Composition
An Additional Level of Complexity or an Achievable Clinical Target?*
































nThe potential of cardiovascular magnetic resonance
(CMR) as a noninvasive imaging tool for charac-
terization of myocardial tissue has long been recog-
nized. However, it was only with the introduction
of late gadolinium enhancement (LGE) imaging in
1999 and 2000 that CMR became the established
gold standard imaging technique for clinical assess-
ment of myocardial necrosis and scarring (1). For
the first time, CMR was able to provide an easily
applicable method to assess irreversible myocardial
tissue damage with exquisitely high resolution and
to predict functional recovery (1). The pivotal role
of CMR as a noninvasive imaging tool to assess
See page 1231
tissue composition was underscored further with
the advent of T2-weighted (T2W) techniques for
edema imaging in ischemic myocardium (2). The
combination of T2W and LGE opened up the field
of CMR to applications in the acute setting, by
providing the imaging correlate of the underlying
pathophysiological changes in acutely injured myo-
cardium. As a result of the difference between area
at risk by T2W and necrosis by LGE, the salvaged
myocardial index (2) has been used as the main
endpoint in clinical trials assessing the efficacy of
invasive treatments for ST-segment elevation myo-
cardial infarction (3,4). However, the validity of
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ebated for various reasons, such as: the well-
nown limitations and artifacts of turbo-spin echo–
ased sequences, which hinder the accuracy and
eliability of the sequences (5); the threshold-based
ost-processing methods (2 SD vs. 5 SD) (6) that
re prone to errors; and the fact that the clinical
eaning of the imaging features as a reflection of
he underlying pathology is not entirely clear (7,8).
In the continuous search for new techniques allow-
ng for an even greater, detailed, and more accurate
ssessment of the myocardium, techniques such as T1
nd T2 mapping have been explored. The great advan-
age of these modalities is thought to be the ability to
rovide a quantitative assessment of the tissue com-
onents on a voxel-by-voxel basis (9), and by doing so,
otentially overcoming the limitations of the standard
echniques that rely on threshold-based post-
rocessing methods to define injury (6,7).
T2-mapping techniques have been previously vali-
ated at 1.5-T in myocardial ischemia (9,10) and in
nflammatory cardiomyopathies (11). The additional
iagnostic value of T2-mapping techniques compared
ith conventional turbo spin echo sequences was
eflected in the increased accuracy in depicting myo-
ardial edema (9) and in distinguishing normal from
amaged myocardium by providing significantly dif-
erent voxel-wise absolute T2 values.
Edema imaging at 3-T has been performed
ainly using T2 preparation module steady-state
ree precession sequences (12) or pre-contrast T1-
apping (13); in this issue of iJACC, for the first
ime, van Heeswijk et al. (14) validate a free-
reathing radial gradient echo T2-mapping tech-
ique at 3-T, demonstrating its accuracy and
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1241black-blood T2W fast spin echo technique. Their
work represents a significant contribution to the
technical developments in parameter-mapping
techniques. Specifically, the investigators provide
further improvement in the assessment of myocar-
dial edema beyond conventional T2W fast spin
echo sequences or bright-blood T2 preparation
odule steady-state free precession techniques. The
alue of higher field strength for clinical imaging
as previously been demonstrated for selected
MR applications and is mostly due to the higher
ignal-to-noise ratio and thus higher spatial and
emporal resolution, which allow for improved sen-
itivity and specificity (15,16).
Although CMR techniques generally benefit
rom the higher field strength, this may not neces-
arily be the case for edema imaging. Techniques
ased on T2W–steady-state free precession are
ensitive to susceptibility artifacts and larger radio-
requency inhomogeneities affecting image quality.
he need for longer breath-hold times to enable T1
recovery between T2 preparation modules may also
hallenge the clinical applicability of 3-T CMR
dema imaging. Although van Heeswijk et al. (14)
o not report the prevalence of artifacts, the intro-
uction of free-breathing T2-mapping segmented
-space radial gradient echo may not only overcome
ome of the limitations described, but it also might
rovide a tool for accurate quantitative assessment
f the change in tissue composition at 3-T and
pecifically to assess myocardial edema. A compar-
son study between 1.5-T and 3-T would be needed
o establish the advantages of higher field strengths
or imaging myocardial edema.
Although using mapping techniques for detailed
uantitative tissue characterization is an attractive
rospect, the aim of providing clinicians with ab-
olute values to derive the exact composition of
he myocardium is quite ambitious, especially in the
urrent early stages of validation. At present, theJ Am Coll Cardiol 2008;51:1581–7. vention Acute Mynd T2-mapping sequences resulting in different
bsolute normal tissue values depending on the field
trength and the scanner manufacturer used. Al-
hough establishing absolute values for tissue char-
cterization seems the natural conclusion to pursue
hen using a quantitative method, it might not be
n achievable and deliverable target, given the
ariety of sequences available. Instead, we may need
o rely on relative changes in signal with respect to
stablished normal reference T1-/T2-values; in or-
der to be able to have an objective quantification of
the extent of LV damage, we will also need a better
understanding of the pathophysiological modifica-
tions occurring in the normal myocardium due to
the natural aging process. Until this is clarified, we
are still dependent on threshold-based methods.
Finally, pre-contrast T1-mapping techniques have
also been validated recently as methods to assess the
area at risk (17), and a better understanding of how
T1 compares with T2-mapping techniques will also
be needed.
It is important to remember that for an imaging
tool to be clinically useful, it has to be applicable in
a wide range of conditions and easy to use and
interpret. LGE has been a great example of this.
However, the clinical applicability of mapping tech-
niques is limited at present and a joint effort needs
to be made to develop a standardized and estab-
lished technique that is of clinical use. In conclu-
sion, the scientific community has the opportunity
to establish an accurate method for detailed tissue
characterization of the myocardium. The key to
success of mapping techniques will depend on the
ability to make such detailed and complex informa-
tion easily deliverable on a broad scale.
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